本文關(guān)鍵詞：基于代謝組學(xué)研究佛手散對血虛小鼠的養(yǎng)血補血作用機制，，由筆耕文化傳播整理發(fā)布。

參考文獻/References:

[1]Hu C, Xu G. Metabolomics and traditional Chinese medicine\[J\]. Trends in Analytical Chemistry, 2014, 61: 207214.
[4]許穎智, 張軍平. 病證結(jié)合在中醫(yī)辨證論治中的地位\[J\]. 中華中醫(yī)藥學(xué)刊, 2008, (11): 23622364.
[5]宋雅楠, 張永煜, 蘇式兵. 代謝組學(xué)在“病證效”結(jié)合研究中的應(yīng)用\[J\]. 世界科學(xué)技術(shù)（中醫(yī)藥現(xiàn)代化）, 2013, 15(4): 628633.
[6]周亞男. 基于“病證結(jié)合”模式的中醫(yī)藥臨床療效評價方法初探\[J\]. 世界科學(xué)技術(shù)（中醫(yī)藥現(xiàn)代化）, 2012, 14(2):14051407.
[7]王階, 王永炎, 郭麗麗. 基于病證結(jié)合的中藥組方模式研究\[J\]. 中國中藥雜志, 2009, 34(1):10151017.
[8]陳可冀, 宋軍. 病證結(jié)合的臨床研究是中西醫(yī)結(jié)合研究的重要模式\[J\]. 繼續(xù)醫(yī)學(xué)教育, 2007, 8(19):1215.
[9]羅國安, 梁瓊麟, 王義明, 等. 中醫(yī)藥系統(tǒng)生物學(xué)發(fā)展及展望\[J\]. 中國天然藥物, 2009, 7(4): 242248.
[10]Nicholson J K, Connelly J,Lindon J C, et al. Metabonomics: a platform for studying drug toxicity and gene function\[J\]. Nature reviews Drug discovery, 2002, 1(2): 153161.
[11]杜冠華. 中藥復(fù)方有效成分組學(xué)研究\[J\]. 中成藥, 2002, 24(11): 5658.
[12]張英豐, 董宇, 朱曉新. 中藥復(fù)方藥代動力學(xué)研究的方法與思考\[J\]. 中國天然藥物, 2008, 6(5): 321324.
[13]徐璡, 許朝霞, 王又聞，等. 基于病證結(jié)合的中醫(yī)證候規(guī)范化研究進展\[J\]. 中華中醫(yī)藥雜志, 2014, 29(1):1416.
[14]羅和古, 陳家旭. 代謝組學(xué)技術(shù)與中醫(yī)證候的研究\[J\]. 中國中醫(yī)藥信息雜志, 2010, 14(5):35.
[15]Zheng X　F, Tian J, Liu P, et al. Analysis of the restorative effect of Buzhongyiqitang in the spleenqi deficiency rat model using 1HNMRbased metabonomics\[J\]. Journal of ethnopharmacology, 2014, 151(2): 912920.
[16]Wang P, Sun H,Lv H, et al. Thyroxine and reserpineinduced changes in metabolic profiles of rat urine and the therapeutic effect of Liu Wei Di Huang Wan detected by UPLCHDMS\[J\]. Journal of pharmaceutical and biomedical analysis, 2010, 53(3): 631645.
[17]李偉霞, 黃美艷, 唐于平, 等. 基于代謝組學(xué)研究佛手散對血虛小鼠的養(yǎng)血補血作用機制\[J\]. 藥學(xué)學(xué)報, 2013, 48(8): 13011306.
[18]王穆, 讓蔚清, 張琪, 等. 四物湯對環(huán)磷酰胺所致血虛證治療后的代謝組學(xué)研究\[J\]. 中國中藥雜志, 2010, 35(5): 630634.
[19]〖JP3〗Liu Y T,Peng J B, Jia H M, et al. UPLCQ/TOF MS standardized 〖JP〗Chinese formula XinKeShu for the treatment of atherosclerosis in a rabbit model\[J\]. Phytomedicine, 2014, 21(11): 13641372.
[20]Liang X, Chen X, Liang Q, et al.Metabonomic study of Chinese medicine Shuanglong formula as an effective treatment for myocardial infarction in rats\[J\]. Journal of proteome research, 2010, 10(2): 790799.
[21]于曉紅, 周亞濱, 孫靜, 等. 養(yǎng)心湯對不穩(wěn)定型心絞痛患者血漿代謝組學(xué)的影響\[J\]. 中國中西醫(yī)結(jié)合雜志, 2013, 33(2): 191198.
[22]Dai W, Wei C, Kong H, et al.Effect of the traditional Chinese medicine tongxinluo on endothelial dysfunction rats studied by using urinary metabonomics based on liquid chromatography–mass spectrometry\[J\]. Journal of pharmaceutical and biomedical analysis, 2011, 56(1): 8692.
[23]彭樹靈, 劉曉偉, 張真瑞, 等. 從代謝組學(xué)的角度探討維胃方對大鼠實驗性胃潰瘍的療效機制\[J\]. 中國中西醫(yī)結(jié)合雜志, 2010, 30(10): 10731077.
[24]〖JP3〗Gou X, Tao Q,Feng Q, et al. Urinary metabonomics characterization 〖JP〗of liver fibrosis induced by CCl in rats and intervention effects of Xia Yu Xue Decoction\[J\]. Journal of pharmaceutical and biomedical analysis, 2013, 74: 6265.
[25]邱云平, 蘇明明, 吳大正, 等. 金復(fù)康對大鼠大腸癌癌前病變的改善作用及尿液代謝物研究\[J\]. 中國中藥雜志, 2008, 33(22): 26532657.
[26]〖JP3〗Zhang H, Fu P,Ke B, et al. Metabolomic analysis of biochemical 〖JP〗changes in the plasma and urine of collageninduced arthritis in rats after treatment with HuangLianJieDuTang\[J\]. Journal of ethnopharmacology, 2014, 154(1): 5564.
[27]Xue L, Wang Y, Liu L, et al. A 1HNMRbased metabonomics study of postmenopausal osteoporosis and intervention effects of erxian decoction in ovariectomized rats\[J\]. International journal of molecular sciences, 2011, 12(11): 76357651.
[28]Liu P,Duan J, Guo J, et al. Plasma metabolic profiling of normal and dysmenorrhea syndrome rats and the effects of XiangFuSiWu Decoction intervention\[J\]. Pharmaceutical biology, 2013, 52(5): 603613.
[29]Liu X J, Zhou Y Z, Li Z F, et al. Anti‐depressant effects of Xiaoyaosan on rat model of chronic unpredictable mild stress: a plasma metabonomics study based on NMR spectroscopy\[J\]. Journal of Pharmacy and Pharmacology, 2012, 64(4): 578588.
[30]Gao X, Zheng X, Li Z, et al. Metabonomic study on chronic unpredictable mild stress and intervention effects of Xiaoyaosan in rats using gas chromatography coupled with mass spectrometry\[J\]. Journal of ethnopharmacology, 2011, 137(1): 690699.
[31]Su Z H, Li S Q,Zou G A, et al. Urinary metabonomics study of antidepressive effect of ChaihuShuGanSan on an experimental model of depression induced by chronic variable stress in rats\[J\]. Journal of pharmaceutical and biomedical analysis, 2011, 55(3): 533539.
[31]黎莉, 孫鵬, 梁瓊麟, 等. 白香丹膠囊干預(yù)經(jīng)前期綜合征肝氣逆證大鼠血清代謝組學(xué)研究\[J\]. 中成藥, 2011, 33(5): 762767.
[32]Sun S, Dai J, Wang W, et al. Metabonomic Evaluation of ZHENG Differentiation and Treatment by Fuzhenghuayu Tablet in HepatitisBCaused Cirrhosis\[J\]. Evidencebased Complementary and Alternative Medicine, 2012, 2012(3): 453503.
[33]Nicholson J K, Lindon J C. Systems biology: metabonomics\[J\].Nature, 2008, 455(7216): 10541056.
[34]肖飛. 從循證醫(yī)學(xué)到精準(zhǔn)醫(yī)學(xué)的思考\[J\]. 中華腎病研究電子雜志, 2014, (3):123128.
[35]Xie B G, Zhang Z R, Gong T, et al. Application of metabonomic strategy to discover an unreported active ingredient in LiuWeiDiHuang pills suppressing betaglucuronidase\[J\]. Analytical & Bioanalytical Chemistry, 2014, 407:609614.
[36]周本宏, 周靜, 吳麗寧, 等. 天麻川芎對偏頭痛模型大鼠尿液內(nèi)源性物質(zhì)代謝的影響\[J\]. 中國實驗方劑學(xué)雜志, 2014, 20(3): 104108.
[37]Xu W, Wang H, Chen G, et al. 1H NMRbased metabonomics study on the toxicity alleviation effect of other traditional Chinese medicines in Niuhuang Jiedu tablet to realgar (As2S2)\[J\]. Journal of ethnopharmacology, 2013, 148(1): 8898.
[38]Wan J B,Bai X, Cai X J, et al. Chemical differentiation of DaChengQiTang, a Chinese medicine formula, prepared by traditional and modern decoction methods using UPLC/QTOFMSbased metabolomics approach\[J\]. Journal of pharmaceutical and biomedical analysis, 2013, 83: 3442.
[39]羅國安, 梁瓊麟, 劉清飛,等. 整合化學(xué)物質(zhì)組學(xué)的整體系統(tǒng)生物學(xué)——中藥復(fù)方配伍和作用機理研究的整體方法論\[J\]. 世界科學(xué)技術(shù)：中醫(yī)藥現(xiàn)代化, 2007, 9(1):1015.
[40]Wei W, Li X, Hao J, et al. Proteomic analysis of functional dyspepsia in stressed rats treated with traditional Chinese medicine “Wei Kangning”\[J\]. Journal of gastroenterology and hepatology, 2011, 26(9): 14251433.
[41]丁鶯, 呂賓, 孟立娜,等. 痛瀉要方對內(nèi)臟高敏感大鼠結(jié)腸黏膜蛋白質(zhì)表達譜的影響\[J\]. 胃腸病學(xué), 2012, 17(11):660664.
[42]〖JP3〗Taylor J, King R D,Altmann T, et al. Application of metabolomics 〖JP〗to plant genotype discrimination using statistics and machine learning\[J\]. Bioinformatics, 2002, 18(S2): S241S248.
[43]張愛華, 孫暉, 閆廣利,等. 中醫(yī)方證代謝組學(xué)——中醫(yī)藥研究的新策略\[J\]. 中國中藥雜志, 2015,40(4)：569576.
[44]殷惠軍, 黃燁. 病證結(jié)合動物模型的研究進展\[J\]. 中國中西醫(yī)結(jié)合雜志, 2013, 33(1):810.
[45]Liu P, Liu S,Tian D, et al. The applications and obstacles of metabonomics in traditional chinese medicine\[J\]. EvidenceBased Complementary and Alternative Medicine, 2012, 2012(1): 945824.

[1]陸嫄,吳璐一,黃任佳,等.基于代謝組學(xué)技術(shù)研究艾灸治療潰瘍性結(jié)腸炎的思考[J].環(huán)球中醫(yī)藥,2013,6(06):450.
[2]宋芳嬌,曾克武,王學(xué)美,等.中藥復(fù)方有效成分組相關(guān)研究方法的研究進展[J].環(huán)球中醫(yī)藥,2012,5(12):951.
　SONG Fang-jiao,ZENG Ke-wu,WANG Xue-mei..Progress of research methods on active ingredient group of Chinese herbal formula[J].,2012,5(11):951.
[3]柏冬 王瑞海 劉麗梅.近十年中藥藥代動力學(xué)新技術(shù)新方法概述[J].環(huán)球中醫(yī)藥,2016,9(07):891.[doi:10.3969/j.issn.1674-1749.2016.07.040]
　BAI Dong,WANG Rui-hai,LIU Li-mei..Review on new technologies and methods of pharmacokinetics of traditional Chinese medicines in recent 10 years[J].,2016,9(11):891.[doi:10.3969/j.issn.1674-1749.2016.07.040]
[4]郭宇,魏瑋,楊儉勤.代謝組學(xué)在病證相關(guān)中藥復(fù)方研究中的應(yīng)用[J].環(huán)球中醫(yī)藥,2015,8(11):1416.[doi:10.3969/j.issn.1674-1749.2015.11.042]
　GUO Yu,WEI Wei,YANG Jian qin..Application of metabonomics in the study of disease integrating with syndrome and Chinese compound medicine[J].,2015,8(11):1416.[doi:10.3969/j.issn.1674-1749.2015.11.042]

  本文關(guān)鍵詞：基于代謝組學(xué)研究佛手散對血虛小鼠的養(yǎng)血補血作用機制，由筆耕文化傳播整理發(fā)布。